Table 8.
| Pharmacological function | Emodin | Baicalein |
| Antibiosis | Escherichia coli, Dysentery Bacillus. Aureus staphylococcus | G+,G- bacterium, fungi, spirilla |
| Anti-inflammation | Inhibiting inflammatory cytokine release, restraining vascular permeability, inhibiting leukotrienes synthesis | Anti-histamin release. anti-arachidonic acid metabolism, restraining vascular permeability, anti-allergy |
| Immunoregulation | Enhance immunity | (-) |
| Inhibiting pancreatin activity | Strongly suppressive effect on multiple pancreatins | Only on trypsogen |
| Protecting liver | Anti-hepatofibrosis, antagonzism of liver damage by CCL4 | Anti-hepatofibrosis, |
| Protecting kidney | Inhibiting kidney compensative hypertrophy. Restraining proliferation of kidney fibroblast, preventing and curing earlier injury of kidney on rats with diabetes | (-) |
| Protecting pancreas | (+) | (-) |
| Cholagog | (+) | (-) |
| Diuresis | (+) | (+) |
| Antioxidation | (+) | (+) |
| Scavenging free-radicals | (+) | (+) |
| Anti-thrombosis | (+) | (+) |
| Circulatory system | Dilative effect on multiple blood vessel, depressing proliferation of vascular smooth muscle cell | Double effects of vasodilatation and vasoconstriction |
| Gastrointestinal tract | Double regulation of isolated intestine, anti-gastric ulcer,reducing gastric acid and pepsin, purgate | Curative effect on acute and chronic gastroenteritis |
| Anti-endotoxemia | (+) | (+) |
| Fever relieving | (–) | (+) |
“+”for positive pharmacological action; “–”for negative pharmacological action.